Social & QoL Behaviors in Parkinson's Disease
Social Behaviors and Quality of Life in Individuals With Parkinson's Disease
1 other identifier
observational
500
1 country
1
Brief Summary
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 8, 2024
CompletedFirst Submitted
Initial submission to the registry
April 18, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 13, 2026
February 1, 2026
3.8 years
April 18, 2024
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Subjective Quality of Life
satisfaction with different aspects of life, such as health and social relationships
through study completion, an average of 1 year
Social Behavior
ability to interact with others
through study completion, an average of 1 year
Activities of Daily Living
ability to complete tasks to be independent
through study completion, an average of 1 year
Mental Health
depression and anxiety symptoms
through study completion, an average of 1 year
Cognition
memory and executive function challenges and strengths
through study completion, an average of 1 year
Study Arms (2)
Parkinson's disease
This group includes adults who: * Have been diagnosed with Parkinsons Disease by a healthcare professional * Are at least 40 years old and * Do not possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
Neurotypical adults
This group includes adults who: * Are at least 40 years old * Do not have a diagnosis of Parkinsons Disease or any form of dementia and * Do not have a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
Interventions
Eligibility Criteria
The study includes both 40+ year old adults with Parkinson's disease and 40+ year old neurotypical adults
You may qualify if:
- Have been diagnosed with Parkinsons Disease by a healthcare professional
- Are at least 40 years old
You may not qualify if:
- Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
- Neurotypical group
- Are at least 40 years old
- Have been diagnosed with Parkinson's disease by a healthcare professional
- Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gregory Wallacelead
Study Sites (1)
The George Washington University
Washington D.C., District of Columbia, 20052, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Wallace, PhD
George Washington University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
April 18, 2024
First Posted
April 25, 2024
Study Start
March 8, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Currently, there is no plan to share participant data with other researchers.